Korytkova 2, 1000 Ljubljana
+386 1 543 7103
tajnistvo.patologija@mf.uni-lj.si
Osveži iskanje
Raziskovalni
Hočevar A, Rotar Z, Jurčić V, Pižem J, Čučnik S, Vizjak A, van den Broeke R, Tomšič M.
. IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults.
Arthritis Res Ther. 2016 18:58 (strani 1-5). DOI 10.1186/s13075-016-0959-4
3.9
Prikaz primera
Onorati M, …….Mlakar J, Popovic M, …..Sestan N.
Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia.
Cell Reports 2016;16:2576-2592.
7.8
Vipotnik Vesnaver T, Tul N, Mehrabi S, Parissone F, Štrafela P, Mlakar J, Pižem J, Korva M, Avšič Župan T, Popović M.
Zika virus associated microcephaly/micrencephaly – fetal brain imaging in comparison with neuropathology.
BJOG 2016
4
Pregledni
McAleese KE, …..Popović M, ……Attems J.
Post-mortem assessment in vascular dementia: advances and aspirations.
BMC Medicine 2016 DOI 10.1186/s12916-0676-5
7.4
Gelpi E, … Popović M et al.
Neuropathological criteria of anti-IgLON5-related tauopathy.
Acta Neuropathol 2016, DOI 10.1007/s00401-016-1591-8.
7.2
Živanović M, Savšek L, Poljak M, Popović M.
Possible pitfalls in the diagnostic of progressive multifocal leukoencephalopathy.
Clinical Neuropathol 2016; 35(2):66-71.
1.2
Oštrić D, Todosijević M, Jeričević A, Šega Jazbec S, Popović M.
A 37-year-old pregnant female with multifocal brain lesions.
Brain Pathology 2016; 26(6):797-798
3.6
Kersnik Levart T, Ferluga D, Vizjak A, Mraz J, Kojc N.
Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
Diagnostic Pathology (2016) 11:94 DOI 10.1186/s13000-016-0547-6
1.8
Luzar B, Shanesmith R, Ramakrishnan R, Fisher C, Calonje E.
Cutaneous epithelioid malignant peripheral nerve sheath tumour: a clinicopathological analysis of 12 cases.
Histopathology 2016; 68: 286-296.
3.5
Luzar B, Tanaka M, Schneider J, Calonje E.
Cutaneous microcystic/reticular schwannoma: a poorly recognized entity.
J Cutan Pathol 2016; 43: 93-100.
1.4
Accessibility Tools